Theorem Clinical Research

BioClinica

Water Street invests in generic injectable drug services company Custopharm

Wednesday, February 4, 2015 01:32 PM

Water Street Healthcare Partners, a strategic investor focused exclusively on the healthcare industry headquartered in Chicago, has invested in Custopharm, a generic injectable drug services company. Water Street's team has committed equity to both acquire and expand the Carlsbad, Calif.-based company. The healthcare firm has recruited William Larkins, Ph.D., former vice president and general manager of Bedford Laboratories, as CEO of Custopharm.

More... »

Quest Diagnostics

BioClinica names John Hubbard CEO

Wednesday, December 3, 2014 01:05 PM

BioClinica, a Pennsylvania-based CRO, has appointed John Hubbard, Ph.D., FCP, as CEO and to its board of directors. Hubbard will assume the CEO position on Jan. 5, 2015 from Mark Weinstein.

More... »


BioClinica Compass wins technology innovation award

Thursday, October 2, 2014 01:32 PM

BioClinica, a provider of outsourced clinical trial services and eClinical Solutions, has announced that its Compass technology, a risk-based monitoring solution that improves overall quality in clinical trials, has won the inaugural Society for Clinical Data Management (SCDM) NextGen Technology Innovation (TIA) Award, presented as part of SCDM's 2014 annual conference.

More... »

BioClinica acquires Blueprint Clinical to boost presence in risk-based monitoring

Monday, June 16, 2014 09:21 AM

In the scramble to harness technology to implement risk-based monitoring (RBM) strategies, BioClinica, a provider of technology-enhanced clinical trial management solutions, is acquiring Blueprint Clinical, a small Washington-based developer of Compass, a specialized software program that evaluates potential risks to patient safety and clinical trial operational performance.

More... »

BioClinica launches Optimizer Enterprise Suite

Wednesday, June 11, 2014 12:46 PM

BioClinica, a provider of specialized outsourced clinical trial services and eClinical Solutions, has launched its Optimizer Enterprise Suite for clinical supply chain planning and optimization. The suite brings both enhanced offerings and new web-based tools to BioClinica's predictive clinical supply planning solution originally introduced in 2010.

More... »

BioClinica sees eClinical growth in Europe

Friday, February 14, 2014 01:45 PM

BioClinica, a global provider of clinical trial management solutions, has announced that Europe was the fastest growing geographic region in 2013 for its eClinical technology products. The company plans continued investments in its European workforce in of operations and sales, potentially doubling its European eClinical presence in 2014.

More... »

BioClinica completes first phase of big data research project

Thursday, November 14, 2013 09:30 AM

BioClinica, a global CRO specializing in technology-enhanced solutions for clinical trials, announced the successful completion of the first phase of a big data research project to develop novel algorithms for the automated analysis of medical images in clinical trials. This work was made possible by a strategic partnership with the Center for Dynamic Data Analytics (CDDA), a National Science Foundation (NSF) sponsored cooperative research center focused on developing scalable methods for handling large amounts of complex industry-related data.

More... »

BioClinica introduces StudyView for trials operational visibility

Wednesday, June 26, 2013 02:45 PM

BioClinica, a global provider of clinical trial management solutions, has introduced StudyView, a clinical trials portal and reporting hub that increases clinical trials operational visibility. StudyView provides one tool to access multiple eClinical applications, as well as analyze and report data across studies. Data visualization tools use real-time data for analytics, informing operational decisions about clinical studies. StudyView is fully integrated with BioClinica's product suite and is 21 CFR Part 11 compliant.

More... »

Grunenthal expands use of BioClinica's Trident

Tuesday, June 25, 2013 12:43 PM

BioClinica, a global provider of clinical trial management solutions, has announced international research-based pharmaceutical Grunenthal will utilize enhancements in Trident IWR/IVR for a global study on pain medication. The three year study will involve 350 patients at 80 sites across 17 countries.

More... »

BioClinica partners for cardiac safety study in China

Monday, June 17, 2013 01:48 PM
Summary not available

More... »


CWWeekly

March 2

Huntingdon Life Sciences-Harlan prepares for rebranding and U.S. expansion to compete with early phase CROs Covance, CRL

Patients' increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

March

Novo Nordisk, Takeda, Servier, Celgene among top sponsors
New gains seen from patient- and site-centric initiatives

Patient reported outcomes take center stage
FDA combining PROs, clinical outcomes in its approval decisions

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

February

Study grants market breaks $13 billion
Volume of clinical activity rising while growth in grant spending slows

Revisiting eClinical Technology Solutions Adoption
While use of established solutions grows, sponsors hesitate on newer tools

Already a subscriber?
Log in to your digital subscription.

Purchase the February issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs